Cargando…

Iron Deficiency and Reduced Muscle Strength in Patients with Acute and Chronic Ischemic Stroke

(1) Introduction: Iron deficiency (ID) contributes to impaired functional performance and reduced quality of life in patients with chronic illnesses. The role of ID in stroke is unclear. The aim of this prospective study was to evaluate the prevalence of ID and to evaluate its association with long-...

Descripción completa

Detalles Bibliográficos
Autores principales: Scherbakov, Nadja, Sandek, Anja, Valentova, Miroslava, Mayer, Antje, von Haehling, Stephan, Jankowska, Ewa, Anker, Stefan D., Doehner, Wolfram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836993/
https://www.ncbi.nlm.nih.gov/pubmed/35160047
http://dx.doi.org/10.3390/jcm11030595
_version_ 1784649814390079488
author Scherbakov, Nadja
Sandek, Anja
Valentova, Miroslava
Mayer, Antje
von Haehling, Stephan
Jankowska, Ewa
Anker, Stefan D.
Doehner, Wolfram
author_facet Scherbakov, Nadja
Sandek, Anja
Valentova, Miroslava
Mayer, Antje
von Haehling, Stephan
Jankowska, Ewa
Anker, Stefan D.
Doehner, Wolfram
author_sort Scherbakov, Nadja
collection PubMed
description (1) Introduction: Iron deficiency (ID) contributes to impaired functional performance and reduced quality of life in patients with chronic illnesses. The role of ID in stroke is unclear. The aim of this prospective study was to evaluate the prevalence of ID and to evaluate its association with long-term functional outcome in patients with ischemic stroke. (2) Patients and Methods: 140 patients (age 69 ± 13 years, BMI 27.7 ± 4.6 kg/m², mean ± SD) admitted to a university hospital stroke Unit, with acute ischemic stroke of the middle cerebral artery were consecutively recruited to this observational study. Study examinations were completed after admission (3 ± 2 days after acute stroke) and at one-year follow up (N = 64, 382 ± 27 days after stroke). Neurological status was evaluated according to the National Institute of Health Stroke Scale (NIHSS) and the modified Rankin scale (mRS). Muscle isometric strength of the non-affected limb was assessed by the maximum handgrip test and knee extension leg test. ID was diagnosed with serum ferritin levels ≤ 100 µg/L (ID Type I) or 100–300 µg/L if transferrin saturation (TSAT) < 20% (ID Type II). (3) Results: The prevalence of ID in acute stroke patients was 48% (N = 67), with about two-thirds of patients (N = 45) displaying ID Type I and one-third (N = 22) Type II. Handgrip strength (HGS) and quadriceps muscle strength were reduced in patients with ID compared to patients without ID at baseline (HGS: 26.5 ± 10.4 vs. 33.8 ± 13.2 kg, p < 0.001 and quadriceps: 332 ± 130 vs. 391 ± 143 N, p = 0.06). One year after stroke, prevalence of ID increased to 77% (p = 0.001). While an improvement of HGS was observed in patients with normal iron status, patients with ID had no improvement in HGS difference (4.6 ± 8.3 vs. −0.7 ± 6.5 kg, p < 0.05). Patients with ID remained with lower HGS compared to patients with normal iron status (28.2 ± 12.5 vs. 44.0 ± 8.6 kg, p < 0.0001). (4) Conclusions: Prevalence of ID was high in patients after acute stroke and further increased one year after stroke. ID was associated with lower muscle strength in acute stroke patients. In patients with ID, skeletal muscle strength did not improve one year after stroke.
format Online
Article
Text
id pubmed-8836993
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88369932022-02-12 Iron Deficiency and Reduced Muscle Strength in Patients with Acute and Chronic Ischemic Stroke Scherbakov, Nadja Sandek, Anja Valentova, Miroslava Mayer, Antje von Haehling, Stephan Jankowska, Ewa Anker, Stefan D. Doehner, Wolfram J Clin Med Article (1) Introduction: Iron deficiency (ID) contributes to impaired functional performance and reduced quality of life in patients with chronic illnesses. The role of ID in stroke is unclear. The aim of this prospective study was to evaluate the prevalence of ID and to evaluate its association with long-term functional outcome in patients with ischemic stroke. (2) Patients and Methods: 140 patients (age 69 ± 13 years, BMI 27.7 ± 4.6 kg/m², mean ± SD) admitted to a university hospital stroke Unit, with acute ischemic stroke of the middle cerebral artery were consecutively recruited to this observational study. Study examinations were completed after admission (3 ± 2 days after acute stroke) and at one-year follow up (N = 64, 382 ± 27 days after stroke). Neurological status was evaluated according to the National Institute of Health Stroke Scale (NIHSS) and the modified Rankin scale (mRS). Muscle isometric strength of the non-affected limb was assessed by the maximum handgrip test and knee extension leg test. ID was diagnosed with serum ferritin levels ≤ 100 µg/L (ID Type I) or 100–300 µg/L if transferrin saturation (TSAT) < 20% (ID Type II). (3) Results: The prevalence of ID in acute stroke patients was 48% (N = 67), with about two-thirds of patients (N = 45) displaying ID Type I and one-third (N = 22) Type II. Handgrip strength (HGS) and quadriceps muscle strength were reduced in patients with ID compared to patients without ID at baseline (HGS: 26.5 ± 10.4 vs. 33.8 ± 13.2 kg, p < 0.001 and quadriceps: 332 ± 130 vs. 391 ± 143 N, p = 0.06). One year after stroke, prevalence of ID increased to 77% (p = 0.001). While an improvement of HGS was observed in patients with normal iron status, patients with ID had no improvement in HGS difference (4.6 ± 8.3 vs. −0.7 ± 6.5 kg, p < 0.05). Patients with ID remained with lower HGS compared to patients with normal iron status (28.2 ± 12.5 vs. 44.0 ± 8.6 kg, p < 0.0001). (4) Conclusions: Prevalence of ID was high in patients after acute stroke and further increased one year after stroke. ID was associated with lower muscle strength in acute stroke patients. In patients with ID, skeletal muscle strength did not improve one year after stroke. MDPI 2022-01-25 /pmc/articles/PMC8836993/ /pubmed/35160047 http://dx.doi.org/10.3390/jcm11030595 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Scherbakov, Nadja
Sandek, Anja
Valentova, Miroslava
Mayer, Antje
von Haehling, Stephan
Jankowska, Ewa
Anker, Stefan D.
Doehner, Wolfram
Iron Deficiency and Reduced Muscle Strength in Patients with Acute and Chronic Ischemic Stroke
title Iron Deficiency and Reduced Muscle Strength in Patients with Acute and Chronic Ischemic Stroke
title_full Iron Deficiency and Reduced Muscle Strength in Patients with Acute and Chronic Ischemic Stroke
title_fullStr Iron Deficiency and Reduced Muscle Strength in Patients with Acute and Chronic Ischemic Stroke
title_full_unstemmed Iron Deficiency and Reduced Muscle Strength in Patients with Acute and Chronic Ischemic Stroke
title_short Iron Deficiency and Reduced Muscle Strength in Patients with Acute and Chronic Ischemic Stroke
title_sort iron deficiency and reduced muscle strength in patients with acute and chronic ischemic stroke
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836993/
https://www.ncbi.nlm.nih.gov/pubmed/35160047
http://dx.doi.org/10.3390/jcm11030595
work_keys_str_mv AT scherbakovnadja irondeficiencyandreducedmusclestrengthinpatientswithacuteandchronicischemicstroke
AT sandekanja irondeficiencyandreducedmusclestrengthinpatientswithacuteandchronicischemicstroke
AT valentovamiroslava irondeficiencyandreducedmusclestrengthinpatientswithacuteandchronicischemicstroke
AT mayerantje irondeficiencyandreducedmusclestrengthinpatientswithacuteandchronicischemicstroke
AT vonhaehlingstephan irondeficiencyandreducedmusclestrengthinpatientswithacuteandchronicischemicstroke
AT jankowskaewa irondeficiencyandreducedmusclestrengthinpatientswithacuteandchronicischemicstroke
AT ankerstefand irondeficiencyandreducedmusclestrengthinpatientswithacuteandchronicischemicstroke
AT doehnerwolfram irondeficiencyandreducedmusclestrengthinpatientswithacuteandchronicischemicstroke